Cancer BiologyCurrent Issues in Molecular BiologyPeer-reviewed
The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer
Georgios Kalampounias, Kalliopi Zafeiropoulou, Theodosia Androutsopoulou…·Panagiotis Katsoris
This study identifies upregulated transcription factors in Bortezomib-resistant prostate cancer cells and suggests targeting them to restore sensitivity to proteasome inhibitors.
9 citations